Understanding Section 232 Trade Actions in the Pharmaceutical Sector

$250

Attendee #1

The new Section 232 tariffs on pharmaceuticals raise broader legal, compliance, and supply chain considerations for companies operating in this sector. This webinar will examine what these measures may mean for manufacturers, importers, and downstream market participants. Our speaker will discuss the practical challenges companies may face in assessing exposure, managing compliance risk, and planning for operational disruption, as well as what steps companies can take to respond.